Key result
Elevated hs-cTnT affects ~19% of childhood leukaemia survivors and tracks with anthracycline dose and deformation.
Why the study?
The determinants of plasma high sensitivity cardiac troponin T levels and their associations with left ventricular myocardial deformation in adult survivors of childhood acute leukaemias were not well characterized.
Are plasma hs-cTnT levels elevated in adult survivors of childhood acute leukaemias, and do they correlate with left ventricular myocardial deformation?
Case-Control (n=142)
Yes
Are plasma hs-cTnT levels elevated in adult survivors of childhood acute leukaemias, and do they correlate with left ventricular myocardial deformation?
Absolute Event Rate: 19% vs 5%
Elevated hs-cTnT levels are present in nearly one-fifth of adult survivors of childhood leukemia and correlate with cumulative anthracycline dose and subclinical left ventricular dysfunction.
Elevated hs-cTnT links to anthracycline dose and worse strain in survivors; leaves open whether serial monitoring improves long-term outcomes.
BACKGROUND: We sought to quantify plasma high sensitivity cardiac troponin (hs-cTnT) levels, their determinants, and their associations with left ventricular (LV) myocardial deformation in adult survivors of childhood acute leukaemias. METHODS AND RESULTS: One hundred adult survivors (57 males) of childhood acute leukaemias, aged 24.1 ± 4.2 years, and 42 age-matched controls (26 males) were studied. Plasma cTnT was determined using a highly sensitive assay. Genotyping of NAD(P)H oxidase and multidrug resistance protein polymorphisms was performed. Left ventricular function was assessed by conventional, three-dimensional, and speckle tracking echocardiography. The medians (interquartile range) of hs-cTnT in male and female survivors were 4.9 (4.2 to 7.2) ng/L and 1.0 (1.0 to 3.5) ng/L, respectively. Nineteen survivors (13 males, 6 females) (19%) had elevated hs-cTnT (>95(th) centile of controls). Compared to those without elevated hs-TnT levels, these subjects had received larger cumulative anthracycline dose and were more likely to have leukaemic relapse, stem cell transplant, and cardiac irradiation. Their LV systolic and early diastolic myocardial velocities, isovolumic acceleration, and systolic longitudinal strain rate were significantly lower. Survivors having CT/TT at CYBA rs4673 had higher hs-cTnT levels than those with CC genotype. Functionally, increased hs-cTnT levels were associated with worse LV longitudinal systolic strain and systolic and diastolic strain rates. CONCLUSIONS: Increased hs-cTnT levels occur in a significant proportion of adult survivors of childhood acute leukaemias and are associated with larger cumulative anthracycline dose received, history of leukaemic relapse, stem cell transplant, and cardiac irradiation, genetic variants in free radical metabolism, and worse LV myocardial deformation.
No takes yet. Share an insight, caveat, or question.
Cheung et al. (2013) conducted a case-control in Adult survivors of childhood acute leukaemias (n=142). Childhood acute leukaemia survivorship vs. Healthy age-matched controls was evaluated on Elevated plasma hs-cTnT (>95th percentile of healthy controls) (95% CI 12.5-27.8). Elevated high sensitivity cardiac troponin T was found in 19% of adult survivors of childhood acute leukaemias and associated with higher cumulative anthracycline doses and worse cardiac deformation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: